Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ: LMRI · Real-Time Price · USD
9.33
-0.38 (-3.91%)
At close: Apr 28, 2026, 4:00 PM EDT
9.34
+0.01 (0.11%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Company Description
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services.
Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Lumexa Imaging Holdings, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Dec 11, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 4,335 |
| CEO | Caitlin Zulla |
Contact Details
Address: 4200 Six Forks Road, Suite 1000 Raleigh, North Carolina 27609 United States | |
| Phone | 919 763 1100 |
| Website | lumexaimaging.com |
Stock Details
| Ticker Symbol | LMRI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.50 |
| CIK Code | 2071288 |
| CUSIP Number | 550249106 |
| ISIN Number | US5502491062 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Caitlin Zulla | Chief Executive Officer and Director |
| Henry Lee Cooper | Executive Chairman |
| J. Anthony Martin | Chief Financial Officer |
| James E. Walker Jr. | Chief Accounting Officer |
| Lachlan Tidmarsh | Chief Information Officer |
| Paul Gilbert | Chief Legal Officer |
| Jill Lewandowski | Chief People Officer |
| Dr. Russell Stewart M.B.A., M.D., M.S. | Chief Medical Officer |
| Rick Grodin | Division President |
| Chris Robertson | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 28, 2026 | ARS | Filing |
| Apr 28, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 28, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 9, 2026 | 8-K | Current Report |
| Mar 30, 2026 | 10-K | Annual Report |
| Mar 26, 2026 | 8-K | Current Report |
| Mar 2, 2026 | 8-K | Current Report |
| Feb 13, 2026 | SCHEDULE 13G | Filing |
| Jan 15, 2026 | 8-K | Current Report |
| Dec 18, 2025 | 8-K | Current Report |